Jerome Sarris
#137,859
Most Influential Person Now
Australian academic
Jerome Sarris's AcademicInfluence.com Rankings
Jerome Sarrispsychology Degrees
Psychology
#3888
World Rank
#4356
Historical Rank
Clinical Psychology
#384
World Rank
#389
Historical Rank
Download Badge
Psychology Biology
Jerome Sarris's Degrees
- Bachelors Psychology University of Melbourne
- Bachelors Naturopathy Southern Cross University
- Masters Psychology University of Melbourne
- PhD Psychiatry University of Melbourne
Similar Degrees You Can Earn
Why Is Jerome Sarris Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jerome Sarris is co-director of Psychae Institute, Professor of Integrative Mental Health at Western Sydney University, Australia, and a visiting scientist at the Florey Institute of Neuroscience and Mental Health at the University of Melbourne, Australia.
Jerome Sarris's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The efficacy of smartphone‐based mental health interventions for depressive symptoms: a meta‐analysis of randomized controlled trials (2017) (616)
- The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. (2019) (593)
- Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. (2017) (435)
- Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. (2010) (426)
- Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence (2011) (395)
- Nutritional medicine as mainstream in psychiatry. (2015) (354)
- Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. (2016) (292)
- A systematic review of insomnia and complementary medicine. (2011) (291)
- A meta‐review of “lifestyle psychiatry”: the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders (2020) (258)
- Lifestyle medicine for depression (2014) (243)
- The Effects of Dietary Improvement on Symptoms of Depression and Anxiety: A Meta-Analysis of Randomized Controlled Trials (2019) (237)
- The “online brain”: how the Internet may be changing our cognition (2019) (186)
- Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. (2012) (171)
- Herbal medicines in the treatment of psychiatric disorders: a systematic review (2007) (170)
- The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. (2011) (160)
- A Randomized, Controlled Trial of Meditation for Work Stress, Anxiety and Depressed Mood in Full-Time Workers (2011) (124)
- Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology (2011) (123)
- Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. (2009) (117)
- Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence (2013) (116)
- The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials (2019) (113)
- Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials (2011) (113)
- Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review (2020) (105)
- Herbal medicines in the treatment of psychiatric disorders: 10‐year updated review (2018) (104)
- S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. (2014) (104)
- The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum (2009) (102)
- Lifestyle management of unipolar depression (2013) (101)
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. (2012) (100)
- Kava in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study (2013) (94)
- Kava for the Treatment of Generalized Anxiety Disorder RCT: Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects (2013) (87)
- Complementary Medicine, Exercise, Meditation, Diet, and Lifestyle Modification for Anxiety Disorders: A Review of Current Evidence (2012) (85)
- Diet as a hot topic in psychiatry: a population‐scale study of nutritional intake and inflammatory potential in severe mental illness (2018) (83)
- International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder (2019) (83)
- Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. (2009) (81)
- International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry (2015) (80)
- Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. (2009) (77)
- N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review (2015) (75)
- The Validity and Value of Self-reported Physical Activity and Accelerometry in People With Schizophrenia: A Population-Scale Study of the UK Biobank (2017) (72)
- Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials (2011) (71)
- Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis (2017) (70)
- Grip Strength Is Associated With Cognitive Performance in Schizophrenia and the General Population: A UK Biobank Study of 476559 Participants (2018) (67)
- GABA‐modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence (2018) (65)
- Complementary medicines (herbal and nutritional products) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD): a systematic review of the evidence. (2011) (63)
- Clinical Naturopathy : An Evidence-Based Guide to Practice (2014) (61)
- N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study (2015) (59)
- The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis (2017) (59)
- Plant-Based Medicines for Anxiety Disorders, Part 1 (2013) (58)
- Nutraceuticals in the treatment of Obsessive Compulsive Disorder (OCD): A review of mechanistic and clinical evidence (2011) (56)
- A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo (2019) (52)
- What Is the Role of Dietary Inflammation in Severe Mental Illness? A Review of Observational and Experimental Findings (2019) (51)
- Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review. (2012) (51)
- Depression and exercise (2008) (50)
- Association Between Muscular Strength and Cognition in People With Major Depression or Bipolar Disorder and Healthy Controls (2018) (48)
- Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants (2021) (47)
- Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. (2012) (46)
- A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression (2017) (45)
- Kava hepatotoxicity solution: A six-point plan for new kava standardization. (2011) (44)
- Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca (2020) (43)
- Digital Technologies in the Treatment of Anxiety: Recent Innovations and Future Directions (2018) (40)
- Ziziphus spinosa seeds for insomnia: A review of chemistry and psychopharmacology. (2017) (38)
- Multiple lifestyle factors and depressed mood: a cross-sectional and longitudinal analysis of the UK Biobank (N = 84,860) (2020) (37)
- Neurocognitive effects of kava (Piper methysticum): a systematic review (2011) (36)
- Handgrip strength is associated with hippocampal volume and white matter hyperintensities in major depression and healthy controls: a U.K. Biobank study. (2019) (36)
- Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression. (2014) (36)
- Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression (2013) (35)
- Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial. (2019) (35)
- St. John's wort for the treatment of psychiatric disorders. (2013) (35)
- Integrative Mental Health (IMH): paradigm, research, and clinical practice. (2012) (32)
- Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial (2015) (32)
- N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms (2016) (32)
- Integrative mental healthcare White Paper: establishing a new paradigm through research, education, and clinical guidelines (2014) (32)
- Contaminant Hepatotoxins as Culprits for Kava Hepatotoxicity – Fact or Fiction? (2013) (31)
- St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double‐blind placebo‐controlled pilot trial (2009) (31)
- Kava, the anxiolytic herb: back to basics to prevent liver injury? (2011) (30)
- Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties (2020) (29)
- The effects of multivitamin supplementation on mood and general well-being in healthy young adults. A laboratory and at-home mobile phone assessment (2013) (29)
- L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. (2019) (29)
- Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? (2011) (29)
- Polyunsaturated fatty acids and suicide risk in mood disorders: A systematic review (2017) (28)
- Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. (2018) (28)
- Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial (2015) (27)
- Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review (2018) (27)
- Participant experiences from chronic administration of a multivitamin versus placebo on subjective health and wellbeing: a double-blind qualitative analysis of a randomised controlled trial (2012) (26)
- Herbal medicine use behaviour in Australian adults who experience anxiety: a descriptive study (2016) (25)
- St John’s Wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26-Week RCT (2012) (25)
- Nutritional Psychiatry: From Concept to the Clinic (2019) (24)
- The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo‐controlled, double‐blind study (2012) (24)
- Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce (2022) (24)
- Lifestyle medicine for depression: A meta-analysis of randomized controlled trials. (2021) (23)
- Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial, (2018) (23)
- A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831) (2015) (23)
- Mind-body medicine for schizophrenia and psychotic disorders: a review of the evidence. (2013) (22)
- Current challenges in appraising complementary medicine evidence (2012) (22)
- ‘Omic’ Genetic Technologies for Herbal Medicines in Psychiatry (2012) (22)
- Escitalopram Efficacy in Depression: A Cross-Ethnicity Examination of the Serotonin Transporter Promoter Polymorphism (2014) (22)
- Clinical depression: an evidence-based integrative complementary medicine treatment model. (2011) (21)
- Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations. (2011) (20)
- Exploring the Effect of Lactium™ and Zizyphus Complex on Sleep Quality: A Double-Blind, Randomized Placebo-Controlled Trial (2017) (20)
- Time for a reassessment of the use of Kava in anxiety? (2009) (20)
- Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm (2021) (20)
- Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial (2016) (20)
- Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study (2019) (20)
- Spectral power and functional connectivity changes during mindfulness meditation with eyes open: A magnetoencephalography (MEG) study in long-term meditators. (2015) (19)
- An integrative collaborative care model for people with mental illness and physical comorbidities (2020) (19)
- The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia (2019) (19)
- The Effects of Multivitamin Supplementation on Diurnal Cortisol Secretion and Perceived Stress (2013) (19)
- Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders (2017) (19)
- Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers (2021) (18)
- Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey (2021) (18)
- Yoga for depression and anxiety symptoms in people with cancer: A systematic review and meta‐analysis (2021) (18)
- Prevalence and predictors of herbal medicine use in adults experiencing anxiety: A critical review of the literature (2015) (17)
- Adjunctive nutrients in first‐episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms (2018) (16)
- Evidence-based herbal and nutritional treatments for anxiety in psychiatric disorders (2017) (16)
- Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum. (2009) (15)
- S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial (2019) (15)
- Comparative Use of Complementary Medicine, Allied Health, and Manual Therapies by Middle-Aged and Older Australian Women (2010) (15)
- Effects of multivitamin, mineral and herbal supplement on cognition in younger adults and the contribution of B group vitamins (2014) (13)
- Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial (2017) (13)
- Complementary Medicine Use by Middle-aged and Older Women (2011) (13)
- An adjunctive antidepressant nutraceutical combination in treating major depression: Study protocol, and clinical considerations (2015) (13)
- The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled, cross-over trial using an aqueous extract of Piper methysticum (2009) (13)
- Harnessing the Four Elements for Mental Health (2019) (13)
- The relationship between dietary quality, serum brain-derived neurotrophic factor (BDNF) level, and the Val66met polymorphism in predicting depression (2017) (12)
- Pilot-Testing of “Healthy Body Healthy Mind”: An Integrative Lifestyle Program for Patients With a Mental Illness and Co-morbid Metabolic Syndrome (2019) (12)
- Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression (2021) (12)
- Nutrient and genetic biomarkers of nutraceutical treatment response in mood and psychotic disorders: a systematic review (2019) (11)
- Chinese herbal medicine for sleep disorders: poor methodology restricts any clear conclusion. (2012) (11)
- EPA and DHA as markers of nutraceutical treatment response in major depressive disorder (2019) (11)
- Does a Medicinal Dose of Kava Impair Driving? A Randomized, Placebo-Controlled, Double-Blind Study (2013) (11)
- A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. (2020) (11)
- Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians (2017) (10)
- Medicinal cannabis and driving: the intersection of health and road safety policy. (2021) (10)
- Herbal medicines and phytochemicals for obsessive-compulsive disorder. (2020) (10)
- Zao Ren An Shen for insomnia: a systematic review with meta-analysis. (2020) (10)
- Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey. (2021) (10)
- Psychedelic medicines for mood disorders: current evidence and clinical considerations (2021) (9)
- Do reductions in ghrelin contribute towards antipsychotic-induced weight gain? (2019) (9)
- Implementation of psychiatric‐focused lifestyle medicine programs in Asia (2015) (9)
- An Explorative Qualitative Analysis of Participants' Experience of Using Kava versus Placebo in an RCT (2010) (9)
- A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder (2020) (9)
- Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trial (2020) (9)
- Participant Characteristics as Modifiers of Response to N-Acetyl Cysteine (NAC) in Obsessive-Compulsive Disorder (2016) (9)
- Potential biomarkers of major depression diagnosis and chronicity (2021) (8)
- Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial (2018) (8)
- Student attitudes towards clinical teaching resources in complementary medicine: a focus group examination of Australian naturopathic medicine students. (2014) (8)
- Pathophysiology of Major Depression by Clinical Stages (2021) (7)
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms (2021) (7)
- Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d’essais randomisés co (2021) (7)
- Naturopathic medicine for treating self-reported depression and anxiety: An observational pilot study of naturalistic practice (2014) (6)
- Naturopathic medicine for treating self-reported depression and anxiety: An observational pilot study of naturalistic practice (2014) (6)
- Herbal Anxiolytics with Sedative Actions (2017) (6)
- Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial (2019) (6)
- Mitochondrial modifying nutrients in treating chronic fatigue syndrome: A 16-week open-label pilot study (2017) (5)
- Whole system research of naturopathy and medical herbalism for improving mood and reducing anxiety (2011) (5)
- Chronic cannabis consumption and physical exercise performance in healthy adults: a systematic review (2020) (5)
- The effect of vitamin C supplementation on mood status in adults: a systematic review and meta-analysis of randomized controlled clinical trials. (2021) (5)
- Effects of a group-based lifestyle medicine for depression: A pilot randomized controlled trial (2021) (4)
- Human Hair Growth Enhancement by Green Tea (2007) (4)
- Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review (2019) (4)
- Zao Ren An Shen capsule for chronic insomnia (2019) (4)
- Reviews of Articles on Medicinal Herbs (2008) (4)
- Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand. (2021) (3)
- Videoconference mind-body group therapy in a public mental health setting: a pilot study (2016) (3)
- Treatment of refractory obsessive–compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study (2021) (3)
- Default Mode Network Modulation by Psychedelics: A Systematic Review (2022) (3)
- Omega-3 Fatty Acid Supplementation for Perinatal Depression and Other Subpopulations? (2020) (3)
- Lifestyle medicine for anxiety symptoms: A meta-analysis of randomized controlled trials. (2022) (3)
- Conditional probability of response or nonresponse of placebo compared with antidepressants or St John's Wort in major depressive disorder. (2013) (3)
- Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo (2019) (3)
- The International Network of Integrative Mental Health (INIMH) (2014) (3)
- Zao Ren An Shen capsule for insomnia: A double-blind, randomized, placebo-controlled trial. (2021) (3)
- Nutrients and herbal supplements for mental health (2014) (3)
- A literature review of the studies concerning selected plant-derived adaptogens and their general function in body with a focus on animal studies. (2022) (2)
- A Case of Acute Problem Gambling Associated With Agomelatine (2018) (2)
- The Relationship between Oxidative Stress and Anxiety in a Healthy Older Population (2021) (2)
- Potential mental and physical benefits of supplementation with a high-dose, B-complex multivitamin/mineral supplement: What is the evidence? (2021) (2)
- Disruptive innovation in psychiatry (2022) (2)
- Cannabidiol (CBD) oil rehashing the research, roles and regulations in Australia (2020) (2)
- Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties (2020) (2)
- N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms (2022) (2)
- Legalization of Psychedelic Substances. (2021) (2)
- A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder (2016) (2)
- Aripiprazole as augmentation therapy in bipolar patients with current minor or subsyndromal mood symptoms (2013) (2)
- The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis – CORRIGENDUM (2017) (2)
- Conducting Research in Herbal and Complementary Medicine (2008) (2)
- Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. (2021) (2)
- Erratum to: Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence (2013) (2)
- Integrative and Complementary Medicine in Psychiatry (2015) (2)
- N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial (2022) (2)
- Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey (2022) (2)
- Lifestyle Medicine for the Prevention and Treatment of Depression (2016) (1)
- Potential Herbal Anxiolytics (2017) (1)
- Is insomnia disorder associated with time in bed extension? (2020) (1)
- Vitamin and mineral supplements: Modern-day malnutrition: Examining the links between mineral deficits and mental health status (2018) (1)
- Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double‐blind, placebo‐controlled trial (2022) (1)
- Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study (2022) (1)
- Pyroluria: Fact or Fiction? (2021) (1)
- Interleukin-6 and total antioxidant capacity levels following N-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder (2020) (1)
- Moderators of ayahuasca’s biological antidepressant action (2022) (1)
- Quality control of cannabis inflorescence and oil products: response factors for the cost-efficient determination of ten cannabinoids by HPLC (2022) (1)
- Nutrition and Mental Health—How the Food We Eat Can Affect Our Mood (2020) (1)
- Health check: Seven nutrients important for mental health - and where to find them (2015) (1)
- Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial (2016) (1)
- Mental health and complementary and alternative medicine (2012) (1)
- Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial (2023) (1)
- Dietary quality and nutrient intake in adults with obsessive–compulsive disorder (2021) (1)
- Black Cohosh and St. John's Wort Combination for Climacteric Symptoms (2007) (0)
- Neurobiological markers of Generalised Anxiety Disorder measured via MRS in the dorsal anterior cingulate (2017) (0)
- Kava for the treatment of Generalised Anxiety Disorder (K-GAD): Neurophysiological and pharmacogenomic anxiolytic biomarkers (2015) (0)
- Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use (2023) (0)
- Bioavailability of Echinacea in Liquid and Tablet Preparations (2007) (0)
- Kava for the treatment of Generalised Anxiety Disorder (The K-GAD Study) (2015) (0)
- Are St John's Wort and SSRI antidepressants really ineffective in depression? (2012) (0)
- Efficacy of lifestyle medicine on sleep quality: A meta-analysis of randomized controlled trials. (2023) (0)
- Cancer survivors' experiences, barriers and preferences with yoga: A cross-sectional survey to inform a yoga intervention. (2022) (0)
- Postgraduate-level naturopathy (2008) (0)
- Corrigendum to "A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder". [J Affect Disord. 15 (2020) 233-238]. (2020) (0)
- Complementary and Alternative Treatments for ADHD: What the Evidence Suggests (2019) (0)
- Clinical overview Lifestyle management of unipolar depression (2013) (0)
- Running header: Plant-Based Anxiolytic Psychopharmacology (2013) (0)
- A Randomized Controlled Trial of the Efficacy of Mitochondrial Agents in the treatment of Depression in Bipolar Disorder (2016) (0)
- Nutraceuticals and phytoceuticals for treating psychiatric disorders: a synopsis of the WFSBP and CANMAT 2022 clinician guidelines (2022) (0)
- Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression (2022) (0)
- S204. NUTRITIONAL DEFICIENCIES AND CLINICAL CORRELATES IN FIRST-EPISODE PSYCHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2018) (0)
- A randomized controlled trial investigating the effects of PCSO-524®, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) ex (2020) (0)
- Diet quality, dietary inflammatory index and body composition as predictors of N-acetylcysteine and mitochondrial agents efficacy in bipolar disorder (2019) (0)
- Alternative Treatments for Obsessive-Compulsive Disorder: Nutraceuticals and Lifestyle Interventions (2019) (0)
- Treatments for Comorbid Anxiety and Mood Disorders (2017) (0)
- Antinociceptive Properties of Eucalyptus Oil (2007) (0)
- Herbal and Complementary Medicine in the Treatment of Depression and Anxiety (2009) (0)
- A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression : mitochondrial (2019) (0)
- S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial (2019) (0)
- Anxiety Factors Complementary Medicine Use by Middle-aged and Older Women : Personality , Mood (2011) (0)
- Can we treat bipolar disorder by targeting mitochondrial function (2018) (0)
- Videoconference mind-body group therapy in a public mental health setting: a pilot study (2016) (0)
- Corrigendum to 'Lifestyle Medicine for Depression: A Meta-Analysis of Randomized Controlled Trials' [Journal of Affective Disorder Volume 284, 1 April 2021, Pages 203-216]. (2021) (0)
- Rhodiola Rosea for Mild to Moderate Depression (2007) (0)
- S24-03 Nutraceuticals in the Treatment of Mood Disorders: A Critique of the Current Evidence (2011) (0)
- An integrative lifestyle medicine model for treating depression (2019) (0)
- Assessing dietary, exercise, and non-pharmacological modalities within psychiatric hospitals. (2022) (0)
- Psychotherapeutic and neurobiological processes associated with ayahuasca’s mental health and wellbeing outcomes: a proposed model and implications for therapeutic use (2022) (0)
- Nutrients and herbal medicine supplements for mental health (2014) (0)
- Botanical anxiolytics, antidepressants and hypnotics (2013) (0)
- The need for evidence-based herbal and nutritional anxiety treatments in psychiatry (2017) (0)
- Chronic generalised anxiety (2010) (0)
- Stress and fatigue (2014) (0)
- P04.10. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations (2012) (0)
- Chapter 4 Bipolar disorder and complementary medicine : current evidence , safety issues , and clinical considerations (2016) (0)
- Adjunctive treatments in major depressive disorder: A double-blind, randomised, placebo-controlled trial using S-Adenosyl Methionine (SAMe) and a combination nutraceutical (2016) (0)
- The relationship between handgrip strength and cognition in major depression, bipolar disorder and healthy controls: a population-scale analysis of 110,067 individuals (2018) (0)
- Immunomodulatory Activity of Broccoli (2007) (0)
This paper list is powered by the following services:
Other Resources About Jerome Sarris
What Schools Are Affiliated With Jerome Sarris?
Jerome Sarris is affiliated with the following schools:
